An open-label 12-month trial of mycophenolate mofetil in myasthenia gravis

被引：0
|
作者：
Gogovska, L. [1 ]
Ljapcev, R. [1 ]
机构：
[1] Dept Neuroimmunol, Neurol Clin, Skopje, Macedonia
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [31] Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial
    Chakravarty, Eliza F.
    Utset, Tammy
    Kamen, Diane L.
    Contreras, Gabriel
    McCune, W. Joseph
    Aranow, Cynthia
    Kalunian, Kenneth
    Massarotti, Elena
    Clowse, Megan E. B.
    Rovin, Brad H.
    Lim, S. Sam
    Majithia, Vikas
    Dall'Era, Maria
    Looney, R. John
    Erkan, Doruk
    Saxena, Amit
    Olsen, Nancy J.
    Ko, Kichul
    Guthridge, Joel M.
    Goldmuntz, Ellen
    Springer, Jessica
    D'Aveta, Carla
    Keyes-Elstein, Lynette
    Barry, Bill
    Pinckney, Ashley
    Mcnamara, James
    James, Judith A.
    LANCET RHEUMATOLOGY, 2024, 6 (03): : e168 - e177
  • [32] Preliminary results of an open label trial of CellCept in myasthenia gravis
    Ciafaloni, E
    Massey, JM
    Sanders, DB
    NEUROLOGY, 2000, 54 (07) : A394 - A394
  • [33] Severe skin reaction related to mycophenolate mofetil for myasthenia gravis
    Levin, N
    Mali, A
    Karussis, D
    CLINICAL NEUROPHARMACOLOGY, 2005, 28 (03) : 152 - 153
  • [34] Lessons from two trials of mycophenolate mofetil in myasthenia gravis
    Sanders, Donald B.
    Siddiqi, Zaeem A.
    MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE, 2008, 1132 : 249 - 253
  • [35] CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil
    Vernino, S
    Salomao, DR
    Habermann, TM
    O'Neill, BP
    NEUROLOGY, 2005, 64 (06) : A49 - A49
  • [36] First experience with mycophenolate mofetil therapy for refractory myasthenia gravis
    Pit'ha, V
    Dolezil, D
    Nováková, I
    Simková, L
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2005, 68 (01) : 4 - 8
  • [37] Two strikes against mycophenolate mofetil therapy for myasthenia gravis
    Hirano M.
    Current Neurology and Neuroscience Reports, 2009, 9 (1) : 400 - 406
  • [38] Mycophenolate mofetil for myasthenia gravis - An analysis of efficacy, safety, and tolerability
    Meriggioli, MN
    Ciafaloni, E
    Al-Hayk, KA
    Rowin, J
    Tucker-Lipscomb, B
    Massey, JM
    Sanders, DB
    NEUROLOGY, 2003, 61 (10) : 1438 - 1440
  • [39] Mycophenolate Mofetil for the Treatment of Chronic Dermatitis: An Open-label Study of 16 Patients
    Jackson, J. Mark
    Fowler, Joseph F., Jr.
    Callen, Jeffrey P.
    Lorenz, Douglas J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (04) : 356 - 362
  • [40] A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
    Derk, Chris T.
    Grace, Elizabeth
    Shenin, Max
    Naik, Manisha
    Schulz, Steffan
    Xiong, Wen
    RHEUMATOLOGY, 2009, 48 (12) : 1595 - 1599
12345